
Michelle M. Boisen, MD, discusses the scoring system for optimal debulking in ovarian cancer.

Your AI-Trained Oncology Knowledge Connection!


Michelle M. Boisen, MD, discusses the scoring system for optimal debulking in ovarian cancer.

Michelle M. Boisen, MD, discusses criteria for selecting patients with ovarian cancer for upfront surgery versus neoadjuvant chemotherapy.

Michelle M. Boisen, MD, discusses the selection of neoadjuvant chemotherapy versus upfront surgery for women with newly diagnosed ovarian cancer.

Published: January 29th 2020 | Updated:

Published: April 7th 2020 | Updated:

Published: April 8th 2020 | Updated: